Year: 1988
Type: letter
Abstract: Continuing supply of Hypurin bovine insulinSir, May I, through the channel of your correspondence column, attempt to resolve the current confusion over the supply of bovine insulin injections.Nordisk/Wellcome have declared their intention to cease production of bovine insulin injections after December 1987.This has resulted in a great deal of activity from manufacturers of 'Human' insulins giving information regarding changing patients from their existing regimen to an alternative insulin.As a result, it is now believed by many physicians that all beef insulins will be unavailable after 1987.C P Pharmaceuticals Limited wish to confirm that the HYPURIN range of highly purified bovine insulins willcontinue to be available.This means that unless the patient's physician decides to change the regimen, existing bovine insulin patients can remain on the same species-based insulin, thus avoiding the difficulties of re-stabilisation.I hope that physicians will find this information helpful when dealing with enquiries from diabetic patients and enable them to reassure these patients on the future supplies of bovine insulin.
Source: Practical Diabetes
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4252017544